Difference between revisions of "Part:BBa K2599013"

 
(31 intermediate revisions by the same user not shown)
Line 3: Line 3:
 
<partinfo>BBa_K2599013 short</partinfo>
 
<partinfo>BBa_K2599013 short</partinfo>
  
NCTU_Formosa 2018 designed a composite part encoding the Lacticin Z sequence [https://parts.igem.org/Part:BBa_K2599005 (BBa_K2599005)], and then combined with a T7 promoter [https://parts.igem.org/Part:BBa_I712074 (BBa_I712074)], a lac operator [https://parts.igem.org/Part:BBa_K1624002 (K1624002)], a ribosome binding site [https://parts.igem.org/Part:BBa_B0034 (BBa_B0034)], intein and chintin binding domain (CBD). Further information of our peptide can be found on our design page.
+
NCTU_Formosa 2018 designed a composite part encoding the Lacticin Z sequence [https://parts.igem.org/Part:BBa_K2599005 (BBa_K2599005)], and then combined with a T7 promoter [https://parts.igem.org/Part:BBa_I712074 (BBa_I712074)], a lac operator [https://parts.igem.org/Part:BBa_K1624002 (K1624002)], a ribosome binding site [https://parts.igem.org/Part:BBa_B0034 (BBa_B0034)], intein and chintin binding domain (CBD) [https://parts.igem.org/Part:BBa_K1465230 (BBa_K1465230)]. Further information of our peptide can be found on our design page.
  
  
Figure 1 biobrick picture
 
T--NCTU_Formosa--Lac.png
 
  
  
<p style="padding-top:20px;font-size:20px"><b>Introduction</b></p>
+
{{#tag:html|<img style="width: 60%; padding-left: 18%;" src="https://static.igem.org/mediawiki/2018/8/8b/T--NCTU_Formosa--Lac_2.png" alt="" />}}
 +
<div style="width:40%; padding-left: 30%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure 1.</b> Composite part of Lacticin Z</p></div>
  
Lacticin Z, produced by <i>Lactoccus lactis</i> QU 14, has no leader sequence or signal peptide.
 
  
 +
<p style="padding-top:20px;font-size:20px"><b>Introduction</b></p>
 +
 +
Lacticin Z, produced by <i>Lactoccus lactis</i> QU 14, has no leader sequence or signal peptide. Also, it exhibits a nanomolar range of MICs against various gram-positve bacteria. Consequently, Lacticin Z indeed shows the best antibacterial activity in our experiment.
  
 
<p style="padding-top:20px;font-size:20px"><b>Mechanism of Lacticin Z</b></p>
 
<p style="padding-top:20px;font-size:20px"><b>Mechanism of Lacticin Z</b></p>
  
 
The bacteriocins inhibit their target organisms through pore formation. Though the mechanism of each inhibition is vary from species to species, the general process is conserved. To see more details, please search for our project page.
 
The bacteriocins inhibit their target organisms through pore formation. Though the mechanism of each inhibition is vary from species to species, the general process is conserved. To see more details, please search for our project page.
 +
 +
 +
{{#tag:html|<img style="width: 25%; padding-left: 38%;" src="https://static.igem.org/mediawiki/2018/b/bc/T--NCTU_Formosa--mechanism.png" alt="" />}}
 +
<div style="width:40%; padding-left: 30%;"><p style="padding-top: 20px; font-size: 10px; text-align: center;"><b>Figure 2.</b> Mechanism of bacteriocin</p></div>
  
  
Line 34: Line 39:
  
 
Lacticin Z is a short peptide that will degrade in a short time. After degradation, this antibacterial peptide is harmless to our environment.
 
Lacticin Z is a short peptide that will degrade in a short time. After degradation, this antibacterial peptide is harmless to our environment.
 +
 +
 +
 +
<p style="padding-top:10px;font-size:20px;"><b>Peptide Prediction</b></p>
 +
 +
NCTU_Formosa 2017 had compeleted a [http://2017.igem.org/Team:NCTU_Formosa/Model peptide prediction model] that can predict
 +
peptide for new function. In this model, they used scoring card method (SCM) for machine learning. This year, NCTU_Formosa 2018 continued to use the same method for predicting antimicrobial peptide, in order to seek more candidates for our project.
 +
 +
Lacticin Z is one of the existing peptides that we predicted to show the function of antimicrobial activity. The score of our prediction is 450.92.
 +
 +
 +
{{#tag:html|<img style="width: 70%; padding-left: 15%;" src="https://static.igem.org/mediawiki/2018/b/b4/T--NCTU_Formosa--Lac_card.png" alt="" />}}
 +
<div style="width:40%; padding-left: 30%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure 3.</b> The prediction result of Lacticin Z.</p></div>
 +
  
  
Line 40: Line 59:
 
===Cloning===
 
===Cloning===
  
We conbined our toxic gene to pSB1C3 backbone and conducted PCR to check the size of our part. The Lacticin Z sequence length is around 153 b.p. For the composite part, the sequence length should be near at 1197 b.p.
+
We conbined our toxic gene to pSB1C3 backbone by the two restriction sites, EcoRI and SpeI, and conducted PCR to check the size of our part. The Lacticin Z sequence length is around 153 b.p. For the composite part, the sequence length should be near at 1197 b.p. There are also some restrictioin sites at the two sides of our target protein, provided for future team to utilize the intein tag.
  
  
Figure 2 PCR
+
 
 +
{{#tag:html|<img style="width: 20%; padding-left: 40%;" src="https://static.igem.org/mediawiki/2018/2/24/T--NCTU_Formosa--Lac_comp.png" alt="" />}}
 +
<div style="width:40%; padding-left: 30%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure 4.</b> PCR product </p></div>
  
  
Line 52: Line 73:
  
  
Figure 3 SDS
+
{{#tag:html|<img style="width: 30%; padding-left: 35%;" src="https://static.igem.org/mediawiki/2018/7/7f/T--NCTU_Formosa--Lac_SDSPAGE.png" alt="" />}}
 +
<div style="width:50%; padding-left: 25%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure 5.</b> SDS-PAGE analysis. M: protein Ladder 5–245 kDa, C: negative control (only intein+CBD ,28 kDa), E: Lacticin Z + intein + CBD (BBa_K2599013, 33.9 kDa)</p></div>
 +
 
 +
 
 +
 
 +
===Inhibition Ability Analysis===
 +
 
 +
To verify the fuction of bacteriocins, we target the major bacteria in soil, <i> Bacillus subtilis</i>. Positive control in the experiment is Ampicillin while the negative control is <i>Bacillus subtilis</i> without adding bacteriocins. We record record OD<sub>600</sub> values of samples with Elisa Reader. The growth curve of <i>Bacillus subtilis</i> can be observed in our resluts.
 +
 
 +
 
 +
 
 +
{{#tag:html|<img style="width: 60%; padding-left: 20%;" src="https://static.igem.org/mediawiki/2018/3/3d/T--NCTU_Formosa--Lac_normalized.png" alt="" />}}
 +
<div style="width:70%; padding-left: 15%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure 6.</b> Normalized growth curve of Bacillus subtilis that showed Lacticin Z inhibiting ability throughout 4 hours.</p></div>
 +
 
 +
 
 +
 
 +
{{#tag:html|<img style="width: 40%; padding-left: 30%;" src="https://static.igem.org/mediawiki/2018/1/1e/T--NCTU_Formosa--Lac_bar.png" alt="" />}}
 +
<div style="width:35%; padding-left: 33%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure 7.</b> Bar diagram that showed percentage resistance of Lacticin Z (96.64%) to Bacillus subtilis after 4 hours.</p></div>
 +
 
 +
 
 +
 
 +
 
 +
<b>Dose Response Assessment</b>
 +
 
 +
We diluted samples into three different concentration, which is 0.5, 0.25 and 0.125 times of primitive samples. The positive control in this experiment is Ampicillin and the negative control is <i>Bacillus subtilis</i> without adding bacteriocins. All the data are triplicated and normalized.
 +
 
 +
 
 +
 
 +
{{#tag:html|<img style="width: 60%; padding-left: 20%;" src="https://static.igem.org/mediawiki/2018/6/67/T--NCTU_Formosa--B0v_dose.png" alt="" />}}
 +
<div style="width:50%; padding-left: 25%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure 8.</b> Bar diagram that showed dose response of Lacticin Z after 4 hours.</p></div>
 +
 
 +
 
 +
 
 +
<p style="padding-top:10px;font-size:20px;"><b>Safety</b></p>
 +
 
 +
In the future, we are going to spray our bio-stimulator into the environment. To make sure whether the bacteria contain anti-microbial peptide will not exist in the final product, we design the processing standards in the laboratory.
 +
 
 +
Bacteriocins are usually heat stable, we use high-temperature sterilization to double make sure our peptide solution does not contain any living E. coli. However, peptides may degrades after long time sterilization. To find out the best fitted time for sterilization, we boiled our bacteriocins for 0, 15, 30, and 45 minutes, and put them on LB Agar plate and cultured it at 37℃ for 16 hours.
 +
 
 +
From the result of the plate, we can easily observe that bacteria exists only in the sample that is not boiled. After fifteen minutes of sterilization, there are no alive bacterias exist.
 +
 
 +
 
 +
 
 +
{{#tag:html|<img style="width: 30%; padding-left: 35%;" src=" " alt="" />}}
 +
<div style="width:70%; padding-left: 15%;"><p style="padding-top: 10px; font-size: 10px; text-align: center;"><b>Figure 9.</b> LB Agar plate of sterilization of Lacticin Z+intein+CBD. (A)Negative control:LB broth. (B)Sterilize for 0 minutes. (C)Sterilize for 15 minutes. (D)Sterilize for 30 minutes. (E)Sterilize for 45 minutes.  </p></div>
 +
 
  
  
Line 68: Line 134:
 
<!-- -->
 
<!-- -->
 
<p style="padding-top:20px;font-size:20px"><b>Reference</b></p>
 
<p style="padding-top:20px;font-size:20px"><b>Reference</b></p>
 +
 +
1. Iwatani, S., et al. (2007). "Characterization and structure analysis of a novel bacteriocin, lacticin Z, produced by Lactococcus lactis QU 14." Biosci Biotechnol Biochem 71(8): 1984-1992.

Latest revision as of 18:56, 17 October 2018


T7 Promoter+RBS+Lacticin Z+intein+CBD

NCTU_Formosa 2018 designed a composite part encoding the Lacticin Z sequence (BBa_K2599005), and then combined with a T7 promoter (BBa_I712074), a lac operator (K1624002), a ribosome binding site (BBa_B0034), intein and chintin binding domain (CBD) (BBa_K1465230). Further information of our peptide can be found on our design page.



Figure 1. Composite part of Lacticin Z


Introduction

Lacticin Z, produced by Lactoccus lactis QU 14, has no leader sequence or signal peptide. Also, it exhibits a nanomolar range of MICs against various gram-positve bacteria. Consequently, Lacticin Z indeed shows the best antibacterial activity in our experiment.

Mechanism of Lacticin Z

The bacteriocins inhibit their target organisms through pore formation. Though the mechanism of each inhibition is vary from species to species, the general process is conserved. To see more details, please search for our project page.


Figure 2. Mechanism of bacteriocin



Features of Lacticin Z

1. Species Specific

Bacteriocins are antimicrobial peptides that will kill or inhibit bcterial strains closely related or non-related to produced bacteria, but will not harm the bacteria themselves by specific immunity proteins. The organisims that Lacticin Z targets including Enterococcus faecium, Bacillus subtilis, Bacillus coagulans, etc. More target organisms can be found on [http://bactibase.hammamilab.org/BAC170 bactibase].

2. Eco-friendly

Since Lacticin Z is a polypeptide naturally produced by bacteria itself and can inhibit other bacteria without much environment impact. It don't pose threat to other organisms like farm animals or humans. Therefore, this toxin will not cause safety problem.

3. Biodegradable

Lacticin Z is a short peptide that will degrade in a short time. After degradation, this antibacterial peptide is harmless to our environment.


Peptide Prediction

NCTU_Formosa 2017 had compeleted a [http://2017.igem.org/Team:NCTU_Formosa/Model peptide prediction model] that can predict peptide for new function. In this model, they used scoring card method (SCM) for machine learning. This year, NCTU_Formosa 2018 continued to use the same method for predicting antimicrobial peptide, in order to seek more candidates for our project.

Lacticin Z is one of the existing peptides that we predicted to show the function of antimicrobial activity. The score of our prediction is 450.92.


Figure 3. The prediction result of Lacticin Z.


Experiment Result

Cloning

We conbined our toxic gene to pSB1C3 backbone by the two restriction sites, EcoRI and SpeI, and conducted PCR to check the size of our part. The Lacticin Z sequence length is around 153 b.p. For the composite part, the sequence length should be near at 1197 b.p. There are also some restrictioin sites at the two sides of our target protein, provided for future team to utilize the intein tag.


Figure 4. PCR product


Expressing

We chose E. coli 2566 strain to express our antibacterial peptides. The expression of Lacticin Z fused with intein was induced by IPTG in E. coli , and intein-enterocin B specifically bound to the column through chitin binding domain would be purified.


Figure 5. SDS-PAGE analysis. M: protein Ladder 5–245 kDa, C: negative control (only intein+CBD ,28 kDa), E: Lacticin Z + intein + CBD (BBa_K2599013, 33.9 kDa)


Inhibition Ability Analysis

To verify the fuction of bacteriocins, we target the major bacteria in soil, Bacillus subtilis. Positive control in the experiment is Ampicillin while the negative control is Bacillus subtilis without adding bacteriocins. We record record OD600 values of samples with Elisa Reader. The growth curve of Bacillus subtilis can be observed in our resluts.


Figure 6. Normalized growth curve of Bacillus subtilis that showed Lacticin Z inhibiting ability throughout 4 hours.


Figure 7. Bar diagram that showed percentage resistance of Lacticin Z (96.64%) to Bacillus subtilis after 4 hours.



Dose Response Assessment

We diluted samples into three different concentration, which is 0.5, 0.25 and 0.125 times of primitive samples. The positive control in this experiment is Ampicillin and the negative control is Bacillus subtilis without adding bacteriocins. All the data are triplicated and normalized.


Figure 8. Bar diagram that showed dose response of Lacticin Z after 4 hours.


Safety

In the future, we are going to spray our bio-stimulator into the environment. To make sure whether the bacteria contain anti-microbial peptide will not exist in the final product, we design the processing standards in the laboratory.

Bacteriocins are usually heat stable, we use high-temperature sterilization to double make sure our peptide solution does not contain any living E. coli. However, peptides may degrades after long time sterilization. To find out the best fitted time for sterilization, we boiled our bacteriocins for 0, 15, 30, and 45 minutes, and put them on LB Agar plate and cultured it at 37℃ for 16 hours.

From the result of the plate, we can easily observe that bacteria exists only in the sample that is not boiled. After fifteen minutes of sterilization, there are no alive bacterias exist.


Figure 9. LB Agar plate of sterilization of Lacticin Z+intein+CBD. (A)Negative control:LB broth. (B)Sterilize for 0 minutes. (C)Sterilize for 15 minutes. (D)Sterilize for 30 minutes. (E)Sterilize for 45 minutes.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 1064
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 787
    Illegal AgeI site found at 877
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 707


Reference

1. Iwatani, S., et al. (2007). "Characterization and structure analysis of a novel bacteriocin, lacticin Z, produced by Lactococcus lactis QU 14." Biosci Biotechnol Biochem 71(8): 1984-1992.